{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:33:30Z","timestamp":1763746410074},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,1,1]],"date-time":"2005-01-01T00:00:00Z","timestamp":1104537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2005,1]]},"DOI":"10.1016\/j.humpath.2004.09.021","type":"journal-article","created":{"date-parts":[[2004,12,30]],"date-time":"2004-12-30T12:22:15Z","timestamp":1104409335000},"page":"36-43","source":"Crossref","is-referenced-by-count":23,"title":["Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor"],"prefix":"10.1016","volume":"36","author":[{"given":"Jesse Chung-Sean","family":"Pang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuk Fei","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer Gek Choo","family":"Teo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai Sang","family":"Poon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-Fu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyin","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho-Keung","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2004.09.021_bib1","series-title":"World Health Organization classification of tumors: pathology and genetics of tumors of the nervous system","first-page":"129","article-title":"Medulloblastoma","author":"Giangaspero","year":"2000"},{"key":"10.1016\/j.humpath.2004.09.021_bib2","series-title":"World Health Organization classification of tumors: pathology and genetics of tumors of the nervous system","first-page":"141","article-title":"Supratentorial neuroectodermal tumor (PNET)","author":"Rorke","year":"2000"},{"key":"10.1016\/j.humpath.2004.09.021_bib3","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJM199412013312207","article-title":"Brain tumors in children","volume":"331","author":"Pollack","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.humpath.2004.09.021_bib4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/(SICI)1097-0142(19990701)86:1<142::AID-CNCR20>3.0.CO;2-Y","article-title":"Medulloblastoma and supratentorial primitive neuroectodermal tumors: an institutional experience","volume":"86","author":"Paulino","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.09.021_bib5","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/sj.bjc.6690525","article-title":"Comparative genomic hybridization and histological variation in primitive neuroectodermal tumours","volume":"80","author":"Nicholson","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.humpath.2004.09.021_bib6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/(SICI)1097-0142(19990715)86:2<331::AID-CNCR18>3.0.CO;2-#","article-title":"Comparative genomic hybridization in patients with supratentorial and infratentorial primitive neuroectodermal tumors","volume":"86","author":"Russo","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2004.09.021_bib7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/415436a","article-title":"Prediction of central nervous system embryonal tumour outcome based on gene expression","volume":"415","author":"Pomeroy","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2004.09.021_bib8","first-page":"2196","article-title":"Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP","volume":"58","author":"Yuan","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.humpath.2004.09.021_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0962-8924(02)00004-1","article-title":"Rho GTPase-activating proteins in cell regulation","volume":"13","author":"Moon","year":"2003","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.humpath.2004.09.021_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/374457a0","article-title":"An essential role for Rac in Ras transformation","volume":"374","author":"Qiu","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2004.09.021_bib11","doi-asserted-by":"crossref","first-page":"11781","DOI":"10.1073\/pnas.92.25.11781","article-title":"A role of Rho in Ras transformation","volume":"92","author":"Qiu","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.humpath.2004.09.021_bib12","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1128\/MCB.17.6.3449","article-title":"Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation","volume":"17","author":"Qiu","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.humpath.2004.09.021_bib13","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/(SICI)1098-1004(200002)15:2<156::AID-HUMU4>3.0.CO;2-4","article-title":"Sequence variants of DLC1 in colorectal and ovarian tumours","volume":"15","author":"Wilson","year":"2000","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.humpath.2004.09.021_bib14","first-page":"7646","article-title":"Genetic and epigenetic alterations of the DLC-1 gene in hepatocellular carcinoma","volume":"63","author":"Wong","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.humpath.2004.09.021_bib15","first-page":"133","article-title":"DNA variants of DLC-1, a candidate tumor-suppressor gene in human hepatocellular carcinoma","volume":"23","author":"Park","year":"2003","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.humpath.2004.09.021_bib16","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0027-5107(03)00081-2","article-title":"Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study","volume":"528","author":"Zheng","year":"2003","journal-title":"Mutat. Res."},{"key":"10.1016\/j.humpath.2004.09.021_bib17","first-page":"6581","article-title":"DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1","volume":"60","author":"Ng","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.humpath.2004.09.021_bib18","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00432-003-0440-z","article-title":"Analysis of DLC-1 expression in human breast cancer","volume":"129","author":"Plaumann","year":"2003","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.humpath.2004.09.021_bib19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.onc.1206064","article-title":"DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity","volume":"22","author":"Yuan","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2004.09.021_bib20","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/sj.onc.1207291","article-title":"DLC-1 operates as a tumor-suppressor gene in human non-small cell lung carcinomas","volume":"23","author":"Yuan","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2004.09.021_bib21","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1038\/sj.onc.1206573","article-title":"Transcriptional silencing of the DLC-1 tumor-suppressor gene by epigenetic mechanism in gastric cancer cells","volume":"22","author":"Kim","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2004.09.021_bib22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0165-4608(02)00674-X","article-title":"Promoter hypermethylation of DLC-1, a candidate tumor-suppressor gene, in several common human cancers","volume":"140","author":"Yuan","year":"2003","journal-title":"Cancer Genet. Cytogenet."},{"key":"10.1016\/j.humpath.2004.09.021_bib23","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1038\/sj.onc.1207246","article-title":"Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells","volume":"23","author":"Zhou","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2004.09.021_bib24","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/sj.onc.1205204","article-title":"Identification of a region of homozygous deletion on 8p22-23.1 in medulloblastoma","volume":"21","author":"Yin","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2004.09.021_bib25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ijc.11689","article-title":"Molecular analysis of PinX1 in medulloblastomas","volume":"109","author":"Chang","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.humpath.2004.09.021_bib26","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/jnen\/60.8.808","article-title":"Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors","volume":"60","author":"Dong","year":"2002","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.humpath.2004.09.021_bib27","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3171\/jns.2001.95.1.0009","article-title":"Identification of novel regions of allelic loss in ependymomas by high-resolution allelotyping with 384 microsatellite markers","volume":"95","author":"Tong","year":"2001","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.humpath.2004.09.021_bib28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/5947","article-title":"Cancer epigenetics comes of age","volume":"21","author":"Jones","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.humpath.2004.09.021_bib29","doi-asserted-by":"crossref","first-page":"10914","DOI":"10.1073\/pnas.90.23.10914","article-title":"Antioncogenes and human cancer","volume":"90","author":"Knudson","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.humpath.2004.09.021_bib30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/1098-2264(2000)9999:9999<::AID-GCC1052>3.0.CO;2-S","article-title":"Aberrant hypermethylation of the major breakpoint cluster region in 17p11.2 in medulloblastomas but not supratentorial PNETs","volume":"30","author":"Fruhwald","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.humpath.2004.09.021_bib31","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1038\/sj.onc.1204613","article-title":"Aberrant promoter methylation of previously unidentified target genes is a common abnormality in medulloblastomas: implications for tumor biology and potential clinical utility","volume":"20","author":"Fruhwald","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2004.09.021_bib32","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1038\/sj.onc.1205446","article-title":"Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines","volume":"21","author":"Harada","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.humpath.2004.09.021_bib33","first-page":"5906","article-title":"Biallelic epigenetic inactivation of the RASSF1A tumor-suppressor gene in medulloblastoma development","volume":"62","author":"Lusher","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.humpath.2004.09.021_bib34","first-page":"4042","article-title":"Extensive genomic abnormalities in childhood medulloblastoma by comparative genomic hybridization","volume":"57","author":"Reardon","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.humpath.2004.09.021_bib35","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1038\/sj.bjc.6690293","article-title":"Comparative genomic hybridization detects many recurrent imbalances in central nervous system primitive neuroectodermal tumours in children","volume":"79","author":"Avet-Loiseau","year":"1999","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.humpath.2004.09.021_bib36","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1074\/jbc.M207943200","article-title":"Oncogenic Ras leads to Rho activation by activating the mitogen-activated protein kinase pathway and decreasing Rho GTPase-activating protein activity","volume":"278","author":"Chen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humpath.2004.09.021_bib37","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B","article-title":"Rho GTPases are over-expressed in human tumors","volume":"81","author":"Fritz","year":"1999","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.humpath.2004.09.021_bib38","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/bjc.1998.23","article-title":"Overexpression of the rhoC gene correlates with progression of ductal adenocarcinoma of the pancreas","volume":"77","author":"Suwa","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.humpath.2004.09.021_bib39","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/01.LAB.0000073128.16098.31","article-title":"Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma","volume":"83","author":"Horiuchi","year":"2003","journal-title":"Lab. Invest."},{"key":"10.1016\/j.humpath.2004.09.021_bib40","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1093\/carcin\/22.8.1139","article-title":"Cerivastatin, an inhibitor of HMG-CoA reductase, inhibits the signaling pathways involved in the invasiveness and metastatic properties of highly invasive breast cancer cell lines: an in vitro study","volume":"22","author":"Denoyelle","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.humpath.2004.09.021_bib41","doi-asserted-by":"crossref","first-page":"7618","DOI":"10.1073\/pnas.0307512101","article-title":"Rational design and characterization of a Rac GTPase-specific small molecule inhibitor","volume":"101","author":"Gao","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817704005453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817704005453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T13:56:19Z","timestamp":1548856579000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817704005453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,1]]}},"alternative-id":["S0046817704005453"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2004.09.021","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2005,1]]}}}